|
KR100491282B1
(ko)
|
1996-07-24 |
2005-05-24 |
워너-램버트 캄파니 엘엘씨 |
통증 치료용 이소부틸가바 및 그의 유도체
|
|
AU752444B2
(en)
*
|
1997-09-18 |
2002-09-19 |
Warner-Lambert Company |
Novel stereoselective processes for the preparation of gabapentin analogues
|
|
US6984659B2
(en)
|
1997-11-18 |
2006-01-10 |
Klinikum Der Albert-Ludwigs Universitaet |
2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
|
|
DE19751062A1
(de)
*
|
1997-11-18 |
1999-07-08 |
Univ Ludwigs Albert |
An 4-Stellung substituierte 2-Pyrrolidinon-Derivate zur Verringerung des extrazellulären Glutamat-Spiegels
|
|
PL341231A1
(en)
*
|
1997-12-16 |
2001-03-26 |
Warner Lambert Co |
4(3)-substitute derivatives of 4(3)aminomethyl(thio)pyrane or piperidine derivatives (analogues of garbapentin), their production and application in treating neurological disorders
|
|
AU2001247762A1
(en)
*
|
2000-03-28 |
2001-10-08 |
Delorenzo, Robert, J |
Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death
|
|
WO2002028881A1
(en)
|
2000-10-06 |
2002-04-11 |
Xenoport, Inc. |
Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
|
|
WO2002032376A2
(en)
|
2000-10-06 |
2002-04-25 |
Xenoport, Inc. |
Bile-acid conjugates for providing sustained systemic concentrations of drugs
|
|
GB2368579A
(en)
*
|
2000-10-31 |
2002-05-08 |
Parke Davis & Co Ltd |
Azole pharmaceutical agents
|
|
US6818787B2
(en)
|
2001-06-11 |
2004-11-16 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
AU2002345638A1
(en)
|
2001-06-11 |
2002-12-23 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
|
US8048917B2
(en)
|
2005-04-06 |
2011-11-01 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
ATE540678T1
(de)
|
2001-06-11 |
2012-01-15 |
Xenoport Inc |
Prodrugs aus gaba-analoga, zusammensetzungen und ihre verwendungen
|
|
US7186855B2
(en)
|
2001-06-11 |
2007-03-06 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US7232924B2
(en)
|
2001-06-11 |
2007-06-19 |
Xenoport, Inc. |
Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
|
|
AU2002316231A1
(en)
|
2002-02-19 |
2003-09-29 |
Xenoport, Inc. |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
|
|
US7026351B2
(en)
|
2002-03-20 |
2006-04-11 |
Xenoport, Inc. |
Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof
|
|
AU2003243180A1
(en)
|
2002-05-17 |
2003-12-12 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
|
US20040092498A1
(en)
*
|
2002-08-16 |
2004-05-13 |
David Blakemore |
Substituted glycine derivatives for use as medicaments
|
|
WO2004052360A1
(en)
|
2002-12-11 |
2004-06-24 |
Xenoport, Inc. |
Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof
|
|
CA2451267A1
(en)
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
BR0316572A
(pt)
|
2002-12-13 |
2005-10-04 |
Warner Lambert Co |
Ligando alfa-2-delta para o tratamento de sintomas do trato variáveis inferior, utilização e produto deste
|
|
JP2007505149A
(ja)
|
2003-09-11 |
2007-03-08 |
ゼノポート，インコーポレイティド |
ギャバ類似体のプロドラッグを用いる尿失禁の治療および／あるいは予防
|
|
ES2334673T3
(es)
|
2003-09-12 |
2010-03-15 |
Pfizer Inc. |
Combinaciones que comprenden ligandos alfa-2-delta e inhibidores de recaptacion de serotonina/noradrenalina.
|
|
WO2005027850A2
(en)
|
2003-09-17 |
2005-03-31 |
Xenoport, Inc. |
Treating or preventing restless legs syndrome using prodrugs of gaba analogs
|
|
SI1677767T1
(sl)
|
2003-10-14 |
2011-11-30 |
Xenoport Inc |
Kristalinična oblika analoga gama-aminomaslene kisline
|
|
CA2548917C
(en)
|
2003-12-11 |
2014-09-23 |
Sepracor Inc. |
Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
|
|
CN101068538A
(zh)
|
2004-11-04 |
2007-11-07 |
什诺波特有限公司 |
加巴喷丁前体药物持续释放口服剂型
|
|
HRP20110634T1
(hr)
|
2006-12-22 |
2011-10-31 |
Recordati Ireland Limited |
KOMBINIRANA TERAPIJA LIGANADA α<SUB>2</SUB>δ I NSAID ZA POREMEĆAJE DONJEG URINARNOG TRAKTA
|
|
AU2008290561A1
(en)
*
|
2007-08-23 |
2009-02-26 |
Novartis Ag |
Aminobenzyl-substituted cyclic sulfones useful as BACE inhibitors
|
|
JP5291123B2
(ja)
|
2008-01-25 |
2013-09-18 |
ゼノポート，インコーポレイティド |
（３ｓ）−アミノメチル−５−ヘキサン酸プロドラッグの結晶形態及びその使用
|
|
US7868043B2
(en)
|
2008-01-25 |
2011-01-11 |
Xenoport, Inc. |
Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
|
|
US7872046B2
(en)
|
2008-01-25 |
2011-01-18 |
Xenoport, Inc. |
Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
|
|
BRPI0919811B1
(pt)
|
2008-10-08 |
2022-04-19 |
Xgene Pharmaceutical Inc |
Conjugados de gaba e métodos de uso dos mesmos
|
|
WO2010084797A1
(ja)
*
|
2009-01-21 |
2010-07-29 |
第一三共株式会社 |
含ヘテロ原子化合物
|
|
US9066853B2
(en)
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
|
US10130715B2
(en)
|
2013-01-28 |
2018-11-20 |
Hector L. Lopez |
Methods of improving tolerability, pharmacodynamics, and efficacy of β-alanine and use therefor
|
|
CA3099775A1
(en)
|
2018-05-14 |
2019-11-21 |
Xgene Pharmaceutical Inc. |
Process for making 1-(acyloxy)-alkyl-carabmate drug conjugates of naproxen and pregabalin
|